CeriBell, Inc. Earnings Per Share (Basic)
CeriBell, Inc. (CBLL) reported Earnings Per Share (Basic) of -$0.51 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-10
- CeriBell, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.51.
- CeriBell, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.52.
- CeriBell, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.36.
- CeriBell, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.37.
- CeriBell, Inc. earnings per share, basic for fiscal 2025 was -$1.46.
- CeriBell, Inc. earnings per share, basic for fiscal 2024 was -$3.39.
- CeriBell, Inc. earnings per share, basic for fiscal 2023 was -$5.56.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.51 10-Q · filed 2026-08-10 | -$1.03 10-Q · filed 2026-08-10 | -$1.40 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.76 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2026-03-31 | -$0.52 10-Q · filed 2026-05-11 | -$0.89 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.26 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.63 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2025-12-31 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$1.11 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.46 10-K · filed 2026-02-24 |
| 2025-09-30 | -$0.37 10-Q · filed 2025-11-04 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.10 10-Q · filed 2025-11-04 | -$1.50 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2025-06-30 | -$0.38 10-Q · filed 2026-08-10 | -$0.73 10-Q · filed 2026-08-10 | -$1.13 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.81 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2025-03-31 | -$0.36 10-Q · filed 2026-05-11 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.48 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$2.29 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2024-12-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$1.25 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$2.26 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$3.39 10-K · filed 2026-02-24 |
| 2024-09-30 | -$1.85 10-Q · filed 2025-11-04 | -$3.46 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$5.02 10-Q · filed 2025-11-04 | -$6.56 derived: net income ÷ weighted average shares · filed 2025-11-04 |
| 2024-06-30 | -$1.61 10-Q · filed 2025-08-05 | -$3.17 10-Q · filed 2025-08-05 | -$4.71 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$6.03 derived: net income ÷ weighted average shares · filed 2025-11-04 |
| 2024-03-31 | -$1.56 10-Q · filed 2025-05-08 | -$3.10 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$4.42 derived: net income ÷ weighted average shares · filed 2025-11-04 | |
| 2023-12-31 | -$1.53 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$2.86 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$5.56 10-K · filed 2025-02-25 | |
| 2023-09-30 | -$1.32 10-Q · filed 2024-11-12 | -$4.02 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |